Uday Popat, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the key takeaways from a panel discussion focused on stem cell transplantation (SCT) in myeloproliferative neoplasms (MPNs), underlining the benefits of early intervention and the inclusion of older patients in treatment. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
